Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid


| Recent articles | share

Weekly growth hormone treatment for children approved by European Medicines Agency

The European Medicines Agency has approved once-weekly administration of lonapegsomatropin (TransCon hGH, Ascendis Pharma) for 3-18 year olds to treat growth hormone deficiency.


Congenital Adrenal Hyperplasia management impacts need for growth therapy

A study published in The Journal of Clinical Endocrinology & Metabolism indicates that children may not need additional growth-promoting therapies if their congenital adrenal hyperplasia is well managed.

Endocrinology Advisor

GrowthMonitor mobile phone app to improve children’s health

Data from a preliminary study of the new, mobile phone app, 'GrowthMonitor' was presented at the Society for Endocrinology annual conference in Edinburgh this week. The app puts monitoring in the hands of parents and may reliably identify treatable growth disorders in children much earlier.

Medical Xpress

Hypothalamic receptor involved in regulating growth and puberty

A team of researchers have identified the melanocortin 3 receptor (MC3R) as a critical component of the hypothalamic signalling process that controls growth and puberty onset in humans. The full study is published in Nature.

BBC News

Metformin can be effective treatment for brain tumours

A mouse study indicates that metformin can slow and retard the growth of a rare type of brain tumour that normally requires untargeted chemo or radiotherapy, according to a study published in Science Translational Medicine.


Ketones may improve cerebral blood flow in obesity

According to a Canadian study, published in the Journal of Physiology, ketone supplementation may improve brain blood flow in people with obesity and protect their cognitive function.

Medical News Today

No evidence found linking HRT and increased dementia risk

A large study investigating the risk of dementia in women taking HRT for menopause symptoms has reassuringly found no evidence of a link, the results are published in the BMJ.